微流體控裝置市場規模、佔有率及成長分析（依產品、材料、應用、最終用戶及地區分類）－2026-2033年產業預測

預計到 2024 年，全球微流體裝置市場規模將達到 276.1 億美元，到 2025 年將成長至 311.4 億美元，到 2033 年將成長至 816.3 億美元，預測期（2026-2033 年）的複合年成長率為 12.8%。

由於微流控裝置在醫療保健、製藥、生物技術和研究等領域的廣泛應用，全球微流體控裝置市場正經歷強勁成長。這些先進的裝置能夠開發出緊湊且便攜的診斷工具，並提供快速且準確的檢測結果。將樣品製備、分析和檢測功能整合到單一平台上，在資源有限的環境中尤其有利。微流體技術已在醫療保健領域廣泛應用，透過小型化實驗室流程，提高了檢測速度和效率，同時減少了樣本和試劑的用量，從而革新了醫學診斷。微流體檢測具有快速出結果、成本節約以及能夠進行多重檢測等優勢，顯著推動了分子診斷、免疫檢測、細胞分析和基因組學等領域對微流控裝置的需求。

全球微流體控裝置市場促進因素

由於醫療保健、製藥和生物技術等各個領域對小型攜帶式解決方案的需求不斷成長，全球微流體控裝置市場正經歷顯著成長。這些裝置面積小、所需樣品量少且功能多樣，非常適合滿足這項需求。微流控裝置能夠在微型化狀態下執行複雜的實驗室流程，同時兼具便攜性和現場分析的可能性，這些優勢正在推動微流體技術的廣泛應用。這一趨勢不僅提高了效率，還促進了各個領域的創新應用，從而推動了市場擴張。

全球微流體控裝置市場限制因素

全球微流體控裝置市場面臨一些限制因素，尤其是在醫療和診斷領域以外的產業。農業、環境監測和食品檢測等產業具有從微流體技術中獲益的巨大潛力，但其應用推廣速度仍緩慢。這種猶豫不決可歸因於人們對這些創新解決方案的認知度較低、基礎設施不足以及對傳統方法的過度依賴。提高潛在終端用戶對微流體控裝置在這些尚未充分開發的領域中的眾多優勢和多樣化應用的認知度，對於推動市場成長至關重要。

全球微流體裝置市場趨勢

全球微流體控裝置市場正呈現強勁成長趨勢，就地檢驗（POC​​T）應用日益普及。這些裝置能夠提供即時診斷結果，幫助醫療專業人員更快做出決策。它們只需少量檢體即可實現快速分析，這一優勢在包括醫院、診所和居家醫療在內的各種醫療環境中都備受重視。尤其是在急診和重症監護環境中，對快速且準確診斷資訊的需求不斷成長，推動了微流體技術的發展。隨著醫療保健趨勢向精準醫療和以患者為中心的護理模式發展，未來對微流體控裝置進行高效診斷的依賴預計將進一步增加。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 原料分析

全球微流體控裝置市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 微流體控裝置
• 微流體組件
  • 微流體晶片
  • 流量和壓力感測器
  • 流量和壓力控制器
  • 微流體控閥
  • 微型幫浦
  • 微型針
  • 其他部件

全球微流體裝置市場規模（按材料和複合年成長率分類）（2026-2033 年）

• 玻璃
• 矽
• 聚合物
• 其他

全球微流體控裝置市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 體外診斷
  • 臨床診斷
  • 就地檢驗
  • 獸醫診斷
• 製藥與生命科學研究與製造
  • 實驗室分析
  • 微量點膠
  • 微反應
• 治療藥物
  • 藥物輸送
  • 穿戴式裝置

全球微流體控裝置市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 製藥和生物技術公司
• 研究所
• 診斷中心
• 醫療設施及其他

全球微流體控裝置市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Bio-Rad Laboratories（USA）
• Illumina（USA）
• PerkinElmer（USA）
• Abbott Laboratories（USA）
• Thermo Fisher Scientific（USA）
• bioMerieux（France）
• Danaher Corporation（USA）
• Agilent Technologies（USA）
• Sphere Fluidics（UK）
• Standard BioTools（formerly Fluidigm Corporation）（USA）
• BD（Becton, Dickinson and Company）（USA）
• IDEX Corporation（USA）
• SMC Corporation（Japan）
• Parker Hannifin Corporation（USA）
• Fortive Corporation（USA）
• Aignep SpA（Italy）
• Lonza Group（Switzerland）
• Emulate（USA）
• Dolomite Bio（UK）

結論與建議

Global Microfluidic Devices Market size was valued at USD 27.61 Billion in 2024 and is poised to grow from USD 31.14 Billion in 2025 to USD 81.63 Billion by 2033, growing at a CAGR of 12.8% during the forecast period (2026-2033).

The market for global microfluidic devices is experiencing robust growth, driven by diverse applications across healthcare, pharmaceuticals, biotechnology, and research sectors. These advanced devices facilitate the creation of compact, portable diagnostic tools that provide rapid and precise results. By integrating functions such as sample preparation, analysis, and detection on a single platform, they are particularly beneficial for resource-limited environments. The healthcare sector has embraced microfluidic technology, transforming medical diagnostics through miniaturized laboratory processes that reduce sample and reagent volumes while enhancing testing speed and efficiency. Microfluidic assays deliver advantages like quicker turnaround times, decreased costs, and the capability for multiplex testing, significantly boosting demand for devices used in molecular diagnostics, immunoassays, cell analysis, and genomics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microfluidic Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microfluidic Devices Market Segments Analysis

Global Microfluidic Devices Market is segmented by Product, Material, Application, End User and region. Based on Product, the market is segmented into Microfluidic-based Devices and Microfluidic Components. Based on Material, the market is segmented into Glass, Silicon, Polymer and Others. Based on Application, the market is segmented into In-vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics. Based on End User, the market is segmented into Pharmaceutical and Biotechnology Companies, Research Institutes, Diagnostic Centers and Healthcare Facilities and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Microfluidic Devices Market

The global microfluidic devices market is experiencing significant growth due to a rising demand for compact and portable solutions across diverse sectors such as healthcare, pharmaceuticals, and biotechnology. These devices excel in addressing this need because of their small footprint, minimal sample size requirements, and multifunctional capabilities. Their ability to conduct intricate laboratory processes in a scaled-down format, coupled with the ease of portability and the potential for on-site analysis, is propelling the widespread adoption of microfluidic technology. This trend is not only enhancing efficiency but also fostering innovative applications across various fields, thereby driving market expansion.

Restraints in the Global Microfluidic Devices Market

The Global Microfluidic Devices market encounters certain restraints, particularly in sectors beyond healthcare and diagnostics. Industries such as agriculture, environmental monitoring, and food testing have the potential to greatly benefit from microfluidic technologies; however, their adoption remains sluggish. This hesitance can be attributed to limited awareness of these innovative solutions, insufficient infrastructure, and a strong dependency on traditional methods. To foster market growth, it is essential to enhance awareness and provide education to potential end-users regarding the numerous advantages and diverse applications of microfluidic devices in these underexplored sectors.

Market Trends of the Global Microfluidic Devices Market

The Global Microfluidic Devices market is witnessing a robust trend towards the increasing adoption of point-of-care testing (POCT) applications. These devices excel in providing immediate diagnostic results, facilitating prompt decision-making by healthcare professionals. Their ability to process small sample volumes and deliver rapid analyses makes them highly valued in diverse healthcare environments, including hospitals, clinics, and home care settings. The demand for swift and accurate diagnostic information, particularly in emergency and critical care scenarios, is propelling the growth of microfluidic technologies. As healthcare trends evolve towards precision medicine and patient-centered care, the reliance on microfluidic devices for efficient diagnostics is expected to surge.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Raw Material Analysis

Global Microfluidic Devices Market Size by Product & CAGR (2026-2033)

• Market Overview
• Microfluidic-based Devices
• Microfluidic Components
  • Microfluidic Chips
  • Flow & Pressure Sensors
  • Flow & Pressure Controllers
  • Microfluidic Valves
  • Micropumps
  • Microneedles
  • Other Components

Global Microfluidic Devices Market Size by Material & CAGR (2026-2033)

• Market Overview
• Glass
• Silicon
• Polymer
• Others

Global Microfluidic Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• In-vitro Diagnostics
  • Clinical Diagnostics
  • Point-of-care Testing
  • Veterinary Diagnostics
• Pharmaceutical & Life Science Research and Manufacturing
  • Lab Analytics
  • Microdispensing
  • Microreaction
• Therapeutics
  • Drug Delivery
  • Wearables Devices

Global Microfluidic Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical and Biotechnology Companies
• Research Institutes
• Diagnostic Centers
• Healthcare Facilities and Others

Global Microfluidic Devices Market Size & CAGR (2026-2033)

• North America (Product, Material, Application, End User)
  • US
  • Canada
• Europe (Product, Material, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Material, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Material, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Material, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sphere Fluidics (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Standard BioTools (formerly Fluidigm Corporation) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEX Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SMC Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parker Hannifin Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fortive Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aignep S.p.A (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emulate (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dolomite Bio (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations